DE10299019I1 - Neues Verfahren zur Herstellung 20-Keto 21-alpha-Hydroxysteroide und Zwischenprodukte dazu - Google Patents

Neues Verfahren zur Herstellung 20-Keto 21-alpha-Hydroxysteroide und Zwischenprodukte dazu

Info

Publication number
DE10299019I1
DE10299019I1 DE2002199019 DE10299019C DE10299019I1 DE 10299019 I1 DE10299019 I1 DE 10299019I1 DE 2002199019 DE2002199019 DE 2002199019 DE 10299019 C DE10299019 C DE 10299019C DE 10299019 I1 DE10299019 I1 DE 10299019I1
Authority
DE
Germany
Prior art keywords
intermediates
alpha
new process
hydroxysteroids
keto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2002199019
Other languages
English (en)
Other versions
DE10299019I2 (de
Inventor
Jean Buendia
Veronique Crocq
Christian Masson
Denis Prat
Michel Vivat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE10299019I1 publication Critical patent/DE10299019I1/de
Application granted granted Critical
Publication of DE10299019I2 publication Critical patent/DE10299019I2/de
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007Cyclic thioketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE10299019C 1992-06-11 1993-06-10 Neues Verfahren zur Herstellung 20-Keto, 21-alpha-Hydroxysteroide und Zwischenprodukte dazu Active DE10299019I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9207047A FR2692267B1 (fr) 1992-06-11 1992-06-11 Nouveau procédé de préparation de composés stéroïdes 20-céto 21alpha-hydroxy et intermédiaires.

Publications (2)

Publication Number Publication Date
DE10299019I1 true DE10299019I1 (de) 2002-11-07
DE10299019I2 DE10299019I2 (de) 2008-06-19

Family

ID=9430627

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69305241T Expired - Lifetime DE69305241T2 (de) 1992-06-11 1993-06-10 Neues Verfahren zur Herstellung 20-Keto, 21-alpha-Hydroxysteroide und Zwischenprodukte dazu
DE10299019C Active DE10299019I2 (de) 1992-06-11 1993-06-10 Neues Verfahren zur Herstellung 20-Keto, 21-alpha-Hydroxysteroide und Zwischenprodukte dazu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69305241T Expired - Lifetime DE69305241T2 (de) 1992-06-11 1993-06-10 Neues Verfahren zur Herstellung 20-Keto, 21-alpha-Hydroxysteroide und Zwischenprodukte dazu

Country Status (13)

Country Link
US (1) US5399685A (de)
EP (1) EP0574317B1 (de)
JP (1) JP3231901B2 (de)
AT (1) ATE143971T1 (de)
CA (1) CA2098146C (de)
DE (2) DE69305241T2 (de)
DK (1) DK0574317T3 (de)
ES (1) ES2092785T3 (de)
FR (1) FR2692267B1 (de)
GR (1) GR3021337T3 (de)
HU (3) HU221970B1 (de)
MX (1) MX9303454A (de)
NL (1) NL300068I1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692267B1 (fr) * 1992-06-11 1995-05-19 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21alpha-hydroxy et intermédiaires.
FR2749012B1 (fr) * 1996-05-22 1998-08-07 Hoechst Marion Roussel Inc Nouveaux steroides 1 ou 6-hydroxyles, leur procede de preparation, leur application a titre de medicament et les compositions pharmaceutiques les renfermant
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
TW200306846A (en) * 2002-04-03 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
ITMI20042001A1 (it) 2004-10-21 2005-01-21 Ind Chimica Srl Processo per la preparazione di 21-idrossi steroidi con controllo della distribuzione epimerica nella posizione c-21

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2149302A1 (en) * 1971-08-19 1973-03-30 Roussel Uclaf 21-methyl pregnadienes prepn - used as progestomimetics
CH629504A5 (en) * 1977-12-14 1982-04-30 Roussel Uclaf 19-Norpregnatetraene derivatives
US4181720A (en) * 1978-04-05 1980-01-01 Syntex (U.S.A.) Inc. Corticosteroid antiinflammatory agents
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
FR2692267B1 (fr) * 1992-06-11 1995-05-19 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21alpha-hydroxy et intermédiaires.

Also Published As

Publication number Publication date
FR2692267B1 (fr) 1995-05-19
FR2692267A1 (fr) 1993-12-17
NL300068I1 (nl) 2002-02-01
DE69305241D1 (de) 1996-11-14
HU221161B1 (en) 2002-08-28
HU221970B1 (hu) 2003-03-28
ES2092785T3 (es) 1996-12-01
DE10299019I2 (de) 2008-06-19
EP0574317B1 (de) 1996-10-09
JP3231901B2 (ja) 2001-11-26
CA2098146A1 (fr) 1993-12-12
MX9303454A (es) 1994-07-29
HU9603208D0 (en) 1997-01-28
EP0574317A1 (de) 1993-12-15
HUT64557A (en) 1994-01-28
HU213673B (en) 1997-09-29
US5399685A (en) 1995-03-21
DK0574317T3 (da) 1996-12-23
HU9603209D0 (en) 1997-01-28
DE69305241T2 (de) 1997-03-06
JPH0665283A (ja) 1994-03-08
HU9301694D0 (en) 1994-01-28
ATE143971T1 (de) 1996-10-15
CA2098146C (fr) 2003-12-30
GR3021337T3 (en) 1997-01-31

Similar Documents

Publication Publication Date Title
DE69322708T2 (de) Neues Verfahren zur Herstellung von 7-(substituierten)-9-[(substistuierter Glycyl)amido]-6-demethyl-6-deoxytetracyclinen
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
DE3583416D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarbonsaeurederivaten und neue 1-amino-1,4-dihydropyridin-2,3-dicarbonsaeurederivate.
DE69207429T2 (de) Verfahren zur herstellung von substituierten piperidinen
ATE90676T1 (de) Dioxyalkylenaryl-dihydropyridine zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung.
DE69305241D1 (de) Neues Verfahren zur Herstellung 20-Keto, 21-alpha-Hydroxysteroide und Zwischenprodukte dazu
ATE144526T1 (de) Neues verfahren zur herstellung 11-keto steroidderivate
DE69400343D1 (de) Neues Verfahren zur Herstellung von 6alpha, 9alphadifluoro-Sterioden und Zwischenprodukte davon
HU9400094D0 (en) New 17,20-epoxy-pregnane derivatives process for producing them and use of them for producing cortizone derivatives and intermadeiates
ATE104313T1 (de) Neue 9-g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien26-s|urederivate,verfahren zur herstellung und heilmittel daraus.
ATE110080T1 (de) Verfahren zur herstellung von 7-alpha- alkoxycephemderivaten.
ATE157655T1 (de) Verfahren zur herstellung von gegebenfalls 2- substituierten 5-chlorimidazolen
ATE128471T1 (de) Neues verfahren zur herstellung delta-9(11)- steroide.
ATE42284T1 (de) Unsymmetrische dihydro-dithiazine, verfahren zu ihrer herstellung und ihre verwendung als riech- und geschmacksstoffe.
DE60008748D1 (de) Fluorinierte diole und verfahren zu ihrer herstellung
DE59002088D1 (de) Neue leukotrien-b 4 -derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE59008713D1 (de) Verfahren zur herstellung von 21-brom-4-pregnen-3,20-dion-derivaten.
ATE142637T1 (de) Neues verfahren zur herstellung von 20-oxo, 17- alpha, 21-dihydroxy derivaten von pregnan und neue zwischenprodukte dafür
HU912862D0 (en) Process for producing pharmaceutical compositions comprising substituted 2-cyclohexene derivatives
DE58900971D1 (de) Verfahren zur herstellung von tetralinderivaten und neue tetralinderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HOECHST MARION ROUSSEL, PUTEAUX, FR

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY CEDEX, FR